What could be causing a patient’s abdominal pain, iron‑deficiency anemia, and new‑onset dysgeusia, and how should it be evaluated and managed?

Evaluation and Management of Abdominal Pain with Iron Deficiency Anemia and Dysgeusia

This triad of abdominal pain, iron deficiency anemia, and altered taste (dysgeusia) demands urgent bidirectional gastrointestinal endoscopy to exclude malignancy, combined with celiac disease screening and assessment for Plummer-Vinson syndrome, while simultaneously initiating oral iron replacement therapy. 1, 2

Immediate Diagnostic Priorities

Confirm Iron Deficiency

• Measure serum ferritin—the single most powerful diagnostic test—along with complete blood count, transferrin saturation, and red cell indices (MCV, MCH). 1, 3
• Serum ferritin may be falsely normal in inflammatory conditions; if equivocal, a hemoglobin rise ≥10 g/L within 2 weeks of iron therapy strongly confirms absolute iron deficiency. 1, 3

Recognize the Clinical Significance of Dysgeusia

• Iron deficiency is a well-established cause of hypogeusia (decreased taste sensation), which typically corresponds with elevated taste thresholds and improves when iron stores are replenished. 4
• The combination of abdominal pain, iron deficiency, and dysgeusia raises concern for chronic iron depletion from gastrointestinal blood loss or malabsorption. 4
• Oral and mucosal signs—angular cheilitis, atrophic glossitis, and koilonychia—reflect chronic iron deficiency and may indicate Plummer-Vinson syndrome, which requires endoscopic evaluation for esophageal webs and concurrent upper gastrointestinal pathology. 2, 5

Mandatory Gastrointestinal Investigation

Bidirectional Endoscopy

• All men and postmenopausal women with unexplained iron deficiency anemia require both upper endoscopy (gastroscopy) and colonoscopy, regardless of symptoms. 1, 3
• Approximately one-third of men and postmenopausal women harbor underlying gastrointestinal pathology, most commonly malignancy (colorectal cancer is seven times more common than gastric cancer). 1, 5
• Upper endoscopy identifies the cause in 30–50% of cases; colonoscopy must be performed even when upper endoscopy reveals a lesion because dual pathology occurs in 10–15% of patients. 3, 5
• Do not accept minor findings (mild esophagitis, small hiatal hernia, erosions) as the sole explanation without completing lower gastrointestinal evaluation. 3, 5

Celiac Disease Screening

• Universal screening is mandatory for all patients with iron deficiency anemia, as celiac disease accounts for 3–5% of cases. 2, 3, 5
• Obtain tissue transglutaminase antibody (IgA type) with total IgA level, and perform duodenal biopsies during upper endoscopy even if serology is negative. 2, 6

Assess for Plummer-Vinson Syndrome

• During upper endoscopy, look for esophageal webs in the proximal esophagus, which combined with iron deficiency and dysgeusia suggest this syndrome. 2
• Complete bidirectional endoscopy even after identifying an esophageal web, because concurrent pathology is present in 1–10% of cases. 2

Targeted History and Physical Examination

Key Historical Elements

• Explicitly inquire about all NSAID use (including over-the-counter products), as chronic NSAID therapy causes occult gastrointestinal bleeding even without ulceration and is frequently unreported. 3, 5
• Ask about chronic proton-pump inhibitor therapy, which impairs iron absorption through hypochlorhydria. 2, 5
• Document menstrual history in premenopausal women (average iron loss 0.3–0.5 mg/day), prior gastrectomy or bariatric surgery, vegetarian diet, blood donation, recurrent epistaxis, and urinary symptoms. 5
• Assess for symptoms suggesting inflammatory bowel disease (chronic diarrhea, weight loss) or small bowel pathology. 6, 7

Physical Examination Findings

• Look for angular cheilitis, glossitis, koilonychia (spoon-shaped nails), and bluish sclerae—all signs of chronic iron deficiency. 5
• Examine for telangiectasias suggesting hereditary hemorrhagic telangiectasia. 5

Iron Replacement Therapy

First-Line Oral Therapy

• Start ferrous sulfate 200 mg three times daily (approximately 65 mg elemental iron per dose) immediately after confirming iron deficiency. 3
• If ferrous sulfate is not tolerated, switch to ferrous gluconate or ferrous fumarate; liquid formulations may improve tolerability. 3
• Add vitamin C (ascorbic acid) to enhance absorption if the hematologic response is suboptimal. 3
• Continue iron supplementation for 3 months after hemoglobin normalizes to fully replenish body stores. 3
• Expected response: hemoglobin should rise by ≥10 g/L within 2 weeks or 2 g/dL within 3–4 weeks. 3

When to Use Intravenous Iron

• Reserve parenteral iron for documented intolerance to at least two different oral iron preparations or confirmed non-compliance. 3
• Intravenous iron does not produce faster hemoglobin rise compared with oral therapy, is costly, painful, and carries anaphylaxis risk. 3

Avoid Transfusion

• Limit blood transfusion to hemodynamically unstable patients or those at risk of cardiovascular compromise from severe anemia. 3
• Do not transfuse stable patients regardless of hemoglobin level. 3

Additional Diagnostic Considerations

Urinalysis

• Perform urinalysis or urine microscopy to exclude urinary tract bleeding (e.g., renal cell carcinoma) as a source of iron loss. 3, 5

Small Bowel Investigation

• Small bowel imaging (capsule endoscopy, CT/MRI enterography) is unnecessary unless anemia is transfusion-dependent, hemoglobin cannot be restored/maintained with iron therapy, or red flags suggest small bowel pathology (involuntary weight loss, elevated CRP). 3, 6
• Wireless capsule endoscopy plays an important role in recurrent or refractory iron deficiency anemia to assess for angiodysplasia or small bowel tumors. 1, 3

Management of Underlying Causes

Address Modifiable Factors

• Discontinue NSAIDs when identified as a contributing factor. 3
• In patients with recurrent iron deficiency anemia and normal repeat endoscopies, eradicate Helicobacter pylori if detected. 3
• Correct dietary iron deficiency when present, but do not assume it is the sole cause—full gastrointestinal investigation remains mandatory. 3

Monitoring and Follow-Up

• After hemoglobin normalizes, check hemoglobin and red cell indices every 3 months for 1 year, then once more after an additional year. 3
• If hemoglobin or MCV falls below normal, resume oral iron therapy and consider checking ferritin in ambiguous cases. 3
• Further diagnostic investigation is warranted only when hemoglobin and MCV cannot be maintained despite adequate iron supplementation. 3

Critical Pitfalls to Avoid

• Do not stop investigation after identifying a single cause—multiple concurrent etiologies occur in 10–15% of patients. 3, 5
• Do not skip celiac disease screening—it is missed in 3–5% of cases when not systematically evaluated. 3, 5
• Do not use parenteral iron as first-line therapy—at least two different oral formulations must be trialed first. 3
• Do not accept dysgeusia as a benign symptom—in the context of iron deficiency and abdominal pain, it signals chronic iron depletion requiring urgent gastrointestinal evaluation. 4